纖維性存活骨基材市場規模、佔有率和成長分析：按產品類型、應用、來源、最終用戶和地區分類 - 產業預測，2026-2033年

2024 年全球纖維活性骨基材(FVBM) 市值為 18.4 億美元，預計到 2033 年將成長至 38 億美元，而 2025 年為 19.9 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

全球纖維活性骨基材（FVBM）市場正經歷顯著成長，這主要整形外科和牙科手術中對有效移植替代方案的需求不斷成長。這種複合支架結合了天然膠原蛋白纖維和脫礦骨基質，能夠高度模擬活骨結構，促進骨形成並最大限度地減少移植排斥反應。隨著老年人口中慢性肌肉骨骼疾病的日益普遍，外科醫生越來越傾向於使用FVBM，因為它能夠快速承載重量並改善患者預後，包括更早的康復和更短的住院時間。此外，有利的醫療政策和法規核准也正在改善市場准入。對生物製造的投資以及在生長因子遞送方面的策略合作進一步推動了市場擴張，使FVBM成為整形外科和牙科領域發展的重要解決方案。

全球纖維骨基材市場的成長要素

骨骼肌肉疾病發生率的不斷上升，以及人口老化，導致對創新骨骼修復解決方案的需求持續成長。隨著臨床醫生日益尋求能夠與天然組織無縫整合的生物材料，纖維狀活性骨基材正逐漸成為一種極具前景的選擇，它兼具機械強度和生物活性，符合手術目標。這種日益成長的臨床支援不僅推動了醫院和專科醫療中心在治療方案中採用該材料，還促進了研究合作和分銷網路的拓展，最終推動了市場成長。此外，隨著患者療效的不斷積累，該技術的臨床優勢得到進一步驗證，從而獲得了整形外科專業人士和醫療保險機構的廣泛認可。

全球纖維活性骨基材市場的限制因素

纖維增強生物骨基質的生產涉及複雜的製程，例如精確的纖維排列、滅菌和嚴格的品管，導致生產成本高昂。這些增加的成本最終會轉嫁給醫療機構，影響產品定價，使得小規模診所和發展中市場難以獲得該產品。因此，注重成本的醫療機構可能會選擇價格較低的生物材料替代品，從而阻礙該產品的整體普及。此外，這些財務限制可能會嚇退潛在投資者，減緩新產品的研發，並阻礙市場成長。這種經濟挑戰限制了該產品在臨床實踐中的廣泛應用，並延緩了治療方案的重大進步。

纖維骨基材市場的全球趨勢

全球纖維活性骨基材市場呈現穩定上升趨勢，這主要得益於整形外科界對這種先進移植解決方案的日益認可，它可用於治療困難骨折和重組手術。外科醫生高度重視其卓越的生物相容性和對供體部位的最小負擔，這與微創手術日益成長的趨勢完美契合。醫院正在重新審視籌資策略，以納入這些創新基質，醫療設備經銷商也在拓展產品線，將其納入其中。這一趨勢的背後是臨床證據的累積、患者對更快康復的需求不斷成長，以及基於療效的報銷模式的轉變，這些都支持了再生性整形外科治療的發展。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球纖維骨基材市場規模：依產品類型分類

• 油灰
• 條
• 可塑性基質

全球纖維骨基材市場規模：按應用領域分類

• 脊椎固定
• 創傷外科
• 整形外科重組
• 足踝外科手術

全球纖維骨基材市場規模：依來源分類

• 同種異體移植
• 去礦物質骨基質

全球纖維骨基材市場規模：依最終用戶分類

• 醫院
• 整形外科診所
• 門診手術中心

全球纖維骨基材市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Johnson & Johnson
• Medtronic plc
• Globus Medical, Inc.
• Orthofix Medical Inc.
• LifeNet Health
• MTF Biologics
• AlloSource
• RTI Surgical Holdings, Inc.
• SeaSpine Holdings Corporation
• Xtant Medical Holdings, Inc.
• Bone Biologics Corporation
• Arthrex, Inc.
• Smith+Nephew plc
• Integra LifeSciences Holdings Corporation
• Exactech, Inc.
• Bioventus Inc.
• Osiris Therapeutics, Inc.
• Surgenex LLC

結論與建議

Global Fiber Viable Bone Matrix Market size was valued at USD 1.84 Billion in 2024 and is poised to grow from USD 1.99 Billion in 2025 to USD 3.8 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global fiber viable bone matrix (FVBM) market is experiencing significant growth, driven by a rising demand for effective graft alternatives in orthopedic and dental procedures. This composite scaffold, which combines natural collagen fibers with demineralized bone matrix, closely resembles native bone architecture, promoting osteogenesis while minimizing graft rejection. As the incidence of chronic musculoskeletal disorders increases among aging populations, surgeons increasingly favor FVBM for its rapid load-bearing capacity and improved patient outcomes, including faster rehabilitation and reduced hospital stays. Additionally, favorable healthcare policies and product regulatory approvals enhance market accessibility. Investments in bio-manufacturing and strategic collaborations in growth-factor delivery further fuel market expansion, positioning FVBM as a pivotal solution in orthopedic and dental advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fiber Viable Bone Matrix market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fiber Viable Bone Matrix Market Segments Analysis

Global fiber viable bone matrix market is segmented by product type, application, source, end user and region. Based on product type, the market is segmented into putty, strip and moldable matrix. Based on application, the market is segmented into spinal fusion, trauma surgery, orthopedic reconstruction and foot & ankle surgery. Based on source, the market is segmented into allograft and demineralized bone matrix. Based on end user, the market is segmented into hospitals, orthopedic clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fiber Viable Bone Matrix Market

The rising incidence of musculoskeletal disorders, coupled with an aging demographic, drives a persistent demand for innovative bone repair solutions. As clinicians increasingly seek biomaterials that seamlessly integrate with natural tissue, fiber viable bone matrix emerges as a favorable option, offering both mechanical strength and bioactive properties that align with surgical goals. This growing clinical preference not only enhances the adoption of such materials in treatment protocols within hospitals and specialty centers but also fosters research partnerships and expands distribution networks, thereby bolstering market growth. Furthermore, accumulating evidence of positive patient outcomes further reinforces the clinical advantages of this technology, leading to broader acceptance among orthopedic professionals and healthcare payers.

Restraints in the Global Fiber Viable Bone Matrix Market

The complex processes involved in manufacturing fiber viable bone matrix, such as precise fiber alignment, sterilization, and thorough quality control, lead to higher production costs. These increased expenses are then passed on to healthcare providers, affecting pricing approaches and making the product less affordable for smaller clinics or developing markets. As a result, cost-sensitive institutions may opt for cheaper biomaterial alternatives, which can hinder overall adoption rates. Additionally, these financial limitations may deter potential investors, slowing the development of new products and stifling market growth. This economic challenge restricts broad clinical implementation and delays valuable advancements in treatment options.

Market Trends of the Global Fiber Viable Bone Matrix Market

The Global Fiber Viable Bone Matrix market is witnessing a robust upward trajectory, fueled by the orthopedic community's increasing endorsement of this advanced grafting solution for challenging fractures and reconstruction. Surgeons appreciate its enhanced biological integration and minimal donor-site morbidity, which aligns seamlessly with the rising trend of minimally invasive surgeries. Hospitals are revising procurement strategies to incorporate these innovative matrices, while medical device distributors are broadening their offerings to include them. This trend is underpinned by an expanding body of clinical evidence, heightened patient demand for quicker recovery times, and a shift towards outcomes-based reimbursement models that favor regenerative orthopedic treatments.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Fiber Viable Bone Matrix Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Putty
• Strip
• Moldable Matrix

Global Fiber Viable Bone Matrix Market Size by Application & CAGR (2026-2033)

• Market Overview
• Spinal Fusion
• Trauma Surgery
• Orthopedic Reconstruction
• Foot & Ankle Surgery

Global Fiber Viable Bone Matrix Market Size by Source & CAGR (2026-2033)

• Market Overview
• Allograft
• Demineralized Bone Matrix

Global Fiber Viable Bone Matrix Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers

Global Fiber Viable Bone Matrix Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Source, End User)
  • US
  • Canada
• Europe (Product Type, Application, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Source, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeNet Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTF Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlloSource
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeaSpine Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Biologics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osiris Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgenex LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations